Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. L-valinyl-l-boroproline
2. Pt 100
3. Pt-100
4. Pt100 Cpd
5. Talabostat
6. Valinyl-boroproline
1. 150080-09-4
2. Val-boropro
3. Talabostat (mesylate)
4. Talabostat Mesilate
5. Talabostat Mesylate [usan]
6. Methanesulfonic Acid ((r)-1-((s)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic Acid (1:1)
7. Pt-100
8. Talabostat Mesylate (usan)
9. V8zg4y1b51
10. Pt100
11. 150080-09-4 (mesylate)
12. [(2r)-1-[(2s)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic Acid Mesylate
13. ((2r)-1-((2s)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic Acid Methanesulfonate
14. (r)-1-((s)-2-amino-3-methylbutanoyl)pyrrolidin-2-ylboronic Acid Methanesulfonic Acid (1:1)
15. Methanesulfonic Acid ((r)-1-((s)-2-amino-3-methyl-butanoyl)pyrrolidin-2-yl)boronic Acid (1:1)
16. Unii-v8zg4y1b51
17. Talabostatmesylate
18. Methanesulfonic Acid Compound With ((r)-1-((s)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic Acid (1:1)
19. Talabostat Methanesulfonic Acid
20. Bxcl 701
21. Schembl4782073
22. Chembl3545064
23. Dtxsid70164466
24. [(2r)-1-[(2s)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic Acid;methanesulfonic Acid
25. Amy14815
26. Bcp04652
27. Ex-a2166
28. Hy-13233a
29. Mfcd13194906
30. S8455
31. Talabostat (val-boropro, Pt-100)
32. Akos016000622
33. Bcp9000205
34. Cs-3187
35. Ac-35958
36. As-73355
37. Talabostat Mesylate; Val-boropro; Pt100
38. Bcp0726000045
39. B3941
40. A14080
41. D05990
42. H11715
43. Val-boropro; Pt100; Pt 100; Pt-100
44. 080t094
45. A903812
46. Q27291679
47. [(2r)-1-[(2s)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic Acid; Methanesulfonic Acid
48. [(2r)-1-[(2s)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic Acidmesylate
49. B-[(2r)-1-[(2s)-2-amino-3-methyl-1-oxobutyl]-2-pyrrolidinyl]boronic Acid Methanesulfonate
50. ((2r)-1-((2s)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic Acid Methanesulphonate
51. Boronic Acid, ((2r)-1-((2s)-2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl) Monomethanesulfonate
52. Boronic Acid, ((2r)-1-((2s)-2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl) Monomethanesulphonate
53. Boronic Acid, ((2r)-1-((2s)-2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-, Monomethanesulfonate
Molecular Weight | 310.18 g/mol |
---|---|
Molecular Formula | C10H23BN2O6S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 310.1369878 g/mol |
Monoisotopic Mass | 310.1369878 g/mol |
Topological Polar Surface Area | 150 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 328 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
84
PharmaCompass offers a list of Talabostat Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Talabostat Mesylate manufacturer or Talabostat Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Talabostat Mesylate manufacturer or Talabostat Mesylate supplier.
PharmaCompass also assists you with knowing the Talabostat Mesylate API Price utilized in the formulation of products. Talabostat Mesylate API Price is not always fixed or binding as the Talabostat Mesylate Price is obtained through a variety of data sources. The Talabostat Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Talabostat Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Talabostat Mesylate, including repackagers and relabelers. The FDA regulates Talabostat Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Talabostat Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Talabostat Mesylate supplier is an individual or a company that provides Talabostat Mesylate active pharmaceutical ingredient (API) or Talabostat Mesylate finished formulations upon request. The Talabostat Mesylate suppliers may include Talabostat Mesylate API manufacturers, exporters, distributors and traders.
Talabostat Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Talabostat Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Talabostat Mesylate GMP manufacturer or Talabostat Mesylate GMP API supplier for your needs.
A Talabostat Mesylate CoA (Certificate of Analysis) is a formal document that attests to Talabostat Mesylate's compliance with Talabostat Mesylate specifications and serves as a tool for batch-level quality control.
Talabostat Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Talabostat Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Talabostat Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Talabostat Mesylate EP), Talabostat Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Talabostat Mesylate USP).